Business Context and Reporting Period
This Form 8-K Current Report was filed by Elevance Health, Inc. on February 8, 2023, regarding an event that occurred on January 30, 2023. The filing details the closing of a multi-tranche debt offering.
Key Financial Metrics
The Company completed the sale of three series of senior notes with an aggregate principal amount of $2.6 billion. The net proceeds received were approximately $2,571.5 million after deducting underwriting discounts and offering expenses.
| Note Series | Principal Amount | Coupon Rate | Maturity Date |
|---|---|---|---|
| 2026 Notes | $500 million | 4.900% | February 8, 2026 |
| 2033 Notes | $1,000 million | 4.750% | February 15, 2033 |
| 2053 Notes | $1,100 million | 5.125% | February 15, 2053 |
Interest is payable semi-annually in arrears. The filing does not provide specific data on current revenue, profit, operating cash flow, or existing debt levels outside of this new issuance.
Material Changes
The primary material change is the increase in long-term debt obligations by $2.6 billion in principal. The Company intends to use the net proceeds for working capital and general corporate purposes, including funding acquisitions, repaying short-term and long-term debt, and repurchasing common stock.
Guidance, Outlook, and Risks
The Indenture governing the Notes does not prohibit or limit the incurrence of additional indebtedness. The Notes are subject to redemption at the Company's option prior to maturity at a price equal to the greater of 100% of the principal amount or the present value of remaining payments plus a specified margin over the Treasury Rate. Additionally, a change of control combined with a downgrade of the Notes below investment grade by Moody's, S&P, and Fitch would trigger a mandatory offer to purchase the Notes at 101% of the principal amount.
Investor Verification Checklist
- Verify the exact net proceeds of $2,571.5 million against the $2.6 billion principal to confirm underwriting costs.
- Review the Company's current liquidity position to assess the impact of the new debt service obligations.
- Confirm the specific allocation of proceeds between debt repayment, acquisitions, and share repurchases in subsequent filings.
- Monitor credit rating actions by Moody's, S&P, and Fitch to evaluate the risk of a change-of-control repurchase trigger.